 Arbutus Biopharma Corp NASDAQ: ABUS is soaring Wednesday after The Patent Trial and Appeals Board turned down Moderna Incs NASDAQ: MRNA appeal to invalidate two of Arbutus patents on drug-delivery technology. A federal appeals court upheld the ruling to not invalidate patents held by Arbutus. 